Ignite Creation Date:
2025-12-24 @ 5:05 PM
Ignite Modification Date:
2025-12-28 @ 10:22 AM
Study NCT ID:
NCT01972750
Status:
UNKNOWN
Last Update Posted:
2016-04-19
First Post:
2013-10-24
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Dovitinib (TKI258) in the Treatment of Patients With Relapsed Glioblastoma
Sponsor:
PD Dr. Martin Glas
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
CTKI258ADE02T
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None